Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen P Hunger

Showing results (211-220 of 346) with videos related to

Pageof 35
Sort By:
Genome Medicine|May 29, 2019
Clinical utility of custom-designed NGS panel testing in pediatric tumorsLea F Surrey, Suzanne P MacFarland, Fengqi Chang, et al.
Blood|February 9, 2010
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemiaRichard C Harvey, Charles G Mullighan, I-Ming Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2022
Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/<i>KMT2A</i> Rearrangements in a Modern Therapy Era: A Retrospective International StudyAndishe Attarbaschi, Anja Möricke, Christine J Harrison, et al.
Cancer Cell|June 16, 2015
Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic LeukemiaSeyedmehdi Shojaee, Rebecca Caeser, Maike Buchner, et al.
The Journal of Clinical Investigation|October 23, 2025
T-cell acute lymphoblastic leukemia exploits a neural proinflammatory pathway to colonize the meningesNitesh D Sharma, Esra'a Keewan, Wojciech Ornatowski, et al.
Cancer Research|October 17, 2020
Evolution of the Epigenetic Landscape in Childhood B Acute Lymphoblastic Leukemia and Its Role in Drug ResistanceShella Saint Fleur-Lominy, Nikki A Evensen, Teena Bhatla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2026
Erratum: Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434Robert J Hayashi, Stuart S Winter, Kimberly P Dunsmore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2020
Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434Robert J Hayashi, Stuart S Winter, Kimberly P Dunsmore, et al.
Clinical Pharmacology and Therapeutics|March 26, 2021
Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase HypersensitivityYiwei Liu, Wenjian Yang, Colton A Smith, et al.
Molecular Cancer Therapeutics|December 16, 2014
Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemiaSanti Suryani, Lauryn S Bracken, Richard C Harvey, et al.
Pageof 35

Showing results (211-220 of 346) with videos related to

Sort By:
Pageof 35
Genome Medicine|May 29, 2019
Clinical utility of custom-designed NGS panel testing in pediatric tumorsLea F Surrey, Suzanne P MacFarland, Fengqi Chang, et al.
Blood|February 9, 2010
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemiaRichard C Harvey, Charles G Mullighan, I-Ming Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2022
Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/<i>KMT2A</i> Rearrangements in a Modern Therapy Era: A Retrospective International StudyAndishe Attarbaschi, Anja Möricke, Christine J Harrison, et al.
Cancer Cell|June 16, 2015
Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic LeukemiaSeyedmehdi Shojaee, Rebecca Caeser, Maike Buchner, et al.
The Journal of Clinical Investigation|October 23, 2025
T-cell acute lymphoblastic leukemia exploits a neural proinflammatory pathway to colonize the meningesNitesh D Sharma, Esra'a Keewan, Wojciech Ornatowski, et al.
Cancer Research|October 17, 2020
Evolution of the Epigenetic Landscape in Childhood B Acute Lymphoblastic Leukemia and Its Role in Drug ResistanceShella Saint Fleur-Lominy, Nikki A Evensen, Teena Bhatla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2026
Erratum: Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434Robert J Hayashi, Stuart S Winter, Kimberly P Dunsmore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2020
Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434Robert J Hayashi, Stuart S Winter, Kimberly P Dunsmore, et al.
Clinical Pharmacology and Therapeutics|March 26, 2021
Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase HypersensitivityYiwei Liu, Wenjian Yang, Colton A Smith, et al.
Molecular Cancer Therapeutics|December 16, 2014
Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemiaSanti Suryani, Lauryn S Bracken, Richard C Harvey, et al.
Pageof 35